PetIQ (PETQ) Stock Price
PetIQ Price
Over the last 9 years PetIQ grew revenue by 23.8% annually, reaching 1.10 B USD. For PetIQ, the net margin of 0.2% is up versus -2.0% a few years ago. The consensus 12-month price target for PetIQ is 31.11 USD, about 0.4% above where the stock trades today. Of 11 analysts, 7 rate the stock a buy — an overall Buy consensus.
PetIQ stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of PetIQ over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how PetIQ stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing PetIQ's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | PetIQ Price |
|---|
PetIQ Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
PetIQ Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.16 | 0.21 | 0.20 | 0.27 | 0.53 | 0.71 | 0.78 | 0.93 | 0.92 | 1.10 | 1.16 | 1.23 | 1.31 | 1.29 | 1.48 |
| – | 27.33 | -2.44 | 33.00 | 98.50 | 34.28 | 10.01 | 19.49 | -1.18 | 19.54 | 5.27 | 6.47 | 6.48 | -1.60 | 14.15 |
| 13.04 | 19.02 | 16.00 | 19.17 | 15.72 | 15.09 | 17.31 | 19.96 | 22.69 | 22.89 | 22.89 | 22.89 | 22.89 | 22.89 | 22.89 |
| 21.00 | 39.00 | 32.00 | 51.00 | 83.00 | 107.00 | 135.00 | 186.00 | 209.00 | 252.00 | 265.28 | 282.44 | 300.75 | 295.95 | 337.83 |
| -8.00 | 3.00 | – | 13.00 | 7.00 | 4.00 | -2.00 | 15.00 | 27.00 | 60.00 | 80.00 | 29.00 | 31.00 | 31.00 | 138.00 |
| -4.97 | 1.46 | – | 4.89 | 1.33 | 0.56 | -0.26 | 1.61 | 2.93 | 5.45 | 6.90 | 2.35 | 2.36 | 2.40 | 9.35 |
| -10.00 | -1.00 | -3.00 | -3.00 | – | -14.00 | -81.00 | -16.00 | -48.00 | 2.00 | 54.00 | 58.00 | 54.00 | 65.00 | 90.00 |
| – | -90.00 | 200.00 | – | – | – | 478.57 | -80.25 | 200.00 | -104.17 | 2,600.00 | 7.41 | -6.90 | 20.37 | 38.46 |
| 29.19 | 29.19 | 12.29 | 13.22 | 21.28 | 23.44 | 25.41 | 29.11 | 28.97 | 29.19 | 29.19 | 29.19 | 29.19 | 29.19 | 29.19 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales PetIQ generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue PetIQ retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare PetIQ's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares PetIQ has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against PetIQ's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
PetIQ stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
PetIQ Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
PetIQ business model & stock analysis
PetIQ SWOT Analysis
Strengths
PetIQ Inc has several strengths that contribute to its success in the market. These include:
- Strong brand reputation and recognition in the pet care industry.
- Diversified portfolio of products and services for pets, including medications, wellness products, and vaccinations.
- Wide distribution network and strong relationships with retailers, allowing for broad market reach.
- Economies of scale resulting from the company's large customer base, enabling cost-effective manufacturing and pricing strategies.
- Robust online presence and e-commerce capabilities, catering to the growing trend of pet owners purchasing pet care products online.
Weaknesses
Despite its strengths, PetIQ Inc faces some weaknesses that could hinder its growth potential. These weaknesses include:
- Reliance on third-party suppliers for certain products, which may lead to supply chain disruptions or quality control issues.
- Limited international presence, primarily operating within the United States market.
- Potential vulnerability to economic downturns, as discretionary spending on pet care products and services may decrease during challenging economic times.
- Intense competition from established players in the pet care industry, potentially impacting market share and profitability.
Opportunities
PetIQ Inc can take advantage of several opportunities in the market to drive growth and expand its business. These opportunities include:
- Increasing pet ownership rates and a growing trend towards humanization of pets, leading to higher demand for pet care products and services.
- Expansion into international markets, tapping into new customer bases and revenue streams.
- Development of innovative products and services to cater to evolving customer preferences and needs within the pet care industry.
- Collaboration and strategic partnerships with veterinarians and pet clinics to enhance brand credibility and establish a stronger market presence.
Threats
PetIQ Inc faces several potential threats that could pose challenges to its business operations and profitability. These threats include:
- Regulatory uncertainties and changes in government policies related to the pet care industry, which may impose additional compliance requirements or affect product pricing and availability.
- Increased competition, both from traditional brick-and-mortar retailers and online-only retailers, potentially leading to pricing pressures and market share erosion.
- Economic recessions or downturns, causing a decrease in consumer spending on non-essential products and services.
- Negative publicity or product recalls, damaging the company's brand reputation and customer trust.
PetIQ Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
PetIQ Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
PetIQ historical P/E ratio, EBIT multiple, and P/S ratio
PetIQ annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
PetIQ shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current PetIQ forecasts and price targets in August 2026
Analyst Price Targets 2026PetIQ Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 8/8/2024 | Downgrade | BuyHold | – | |
| 5/10/2024 | Maintained | Buy | 71 | |
| 3/19/2024 | Maintained | Buy | 47 | |
| 10/2/2023 | Maintained | Buy | – | |
| 10/1/2023 | Maintained | Buy | – | |
| 8/15/2023 | Maintained | Buy | 71 | |
| 8/14/2023 | Maintained | Buy | 71 | |
| 10/25/2022 | Maintained | Outperform | 74 | |
| 10/24/2022 | Maintained | Outperform | 74 | |
| 8/10/2022 | Maintained | Outperform | 74 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
PetIQ Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 5/7/2024 | 0.46USD | - | 313.03 MUSD | - | 2024 Q1 |
| 2/26/2024 | -0.31USD | - | 192.64 MUSD | - | 2023 Q4 |
| 11/7/2023 | 0.29USD | - | 227.92 MUSD | - | 2023 Q3 |
| 8/7/2023 | 0.50USD | - | 279.74 MUSD | - | 2023 Q2 |
| 5/2/2023 | 0.41USD | - | 279.57 MUSD | - | 2023 Q1 |
| 2/27/2023 | 0.03USD | - | 196.47 MUSD | - | 2022 Q4 |
| 11/9/2022 | 0.06USD | - | 207.40 MUSD | - | 2022 Q3 |
| 8/9/2022 | 0.34USD | - | 263.30 MUSD | - | 2022 Q2 |
| 5/4/2022 | 0.38USD | - | 273.38 MUSD | - | 2022 Q1 |
| 3/1/2022 | 0.02USD | - | 173.11 MUSD | - | 2021 Q4 |
EESG©
Eulerpool ESG Scorecard© for the PetIQ stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
PetIQ shareholder structure
| % | Name |
|---|---|
0.38219% | |
0.33208% | |
0.31984% | |
0.20067% | |
0.12864% | |
0.09699% |
PetIQ Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
40.20% | SEC ↗ | |
16.30% | SEC ↗ | |
16.30% | SEC ↗ | |
15.22% | SEC ↗ | |
15.22% | SEC ↗ | |
12.55% | SEC ↗ | |
11.00% | SEC ↗ | |
11.00% | SEC ↗ | |
8.67% | SEC ↗ | |
8.67% | SEC ↗ |
PetIQ Executives and Management Board
9 members · avg. age 50 · 11 % women
Mr. Michael Smith (46)
President, Chief Operating Officer
5.94 M USD
Management
Mr. McCord Christensen (51)
Chairman of the Board, Chief Executive Officer · since 2010
Mr. Zvi Glasman (60)
Chief Financial Officer
Mr. John Pearson (37)
Executive Vice President - Services and Manufactured Products
Mr. William Carter (54)
Executive Vice President, General Counsel
Board of Directors
Mr. Bart Becht
Director
Mr. Chris Kelly
Director
Ms. Sarah Nesi
Director
Mr. Tim Stone
Director
PetIQ Supply Chain
PetIQ Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.06 | 0.88 | 0.76 | ||
| 2 | Rite Aid | 0.30 | 0.75 | 0.69 | |
| 3 | 0.57 | 0.72 | 0.61 |
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.40 | -0.76 | — | ||
| 2 | -0.04 | 0.72 | — | ||
| 3 | 0.03 | -0.82 | -0.81 | ||
| 4 | 0.60 | -0.75 | -0.77 | ||
| 5 | -0.09 | -0.57 | -0.71 |
Frequently asked questions about PetIQ
The business model of PetIQ Inc revolves around providing affordable veterinary health and wellness products and services for pets. PetIQ operates through a retail network, offering over-the-counter pet medications, prescription medications, and other pet health products. Additionally, the company provides pet wellness plans, veterinary services, and veterinary-grade pet products through partnerships with leading retailers and e-commerce platforms. By providing accessible, high-quality pet healthcare solutions, PetIQ aims to enhance the overall well-being and longevity of pets.
PetIQ Inc is primarily active in the pet health and wellness industry.
The main competitors of PetIQ Inc in the market include companies such as Zoetis Inc, IDEXX Laboratories, and Elanco Animal Health.
PetIQ Inc is a leading pet health and wellness company, specializing in accessible and affordable veterinary services. Established in 2010, PetIQ has swiftly grown into a prominent player in the pet care industry. The company operates a national network of veterinary clinics and offers an extensive array of pet medications and health products. With a dedication to providing high-quality care at affordable prices, PetIQ has gained a strong reputation among pet owners. Their commitment to pets' well-being has positioned PetIQ as a trusted name in the industry.
Some significant milestones that PetIQ Inc, a leading pet health and wellness company, has achieved include successfully expanding its product portfolio to offer various pet medications, veterinary services, and wellness products. PetIQ has also established partnerships with major retailers, enabling them to reach a wider customer base. The company has experienced substantial revenue growth and successfully conducted an initial public offering (IPO) in 2017. In addition, PetIQ has focused on enhancing its e-commerce capabilities, providing convenient online shopping for pet owners. Overall, PetIQ Inc has made significant strides in becoming a prominent player in the pet care industry.
PetIQ Inc is primarily present in the United States. With its headquarters based in Eagle, Idaho, the company operates nationwide, providing essential pet health and wellness products and services. PetIQ Inc serves pet owners and veterinary clinics across all states in the US, offering a comprehensive range of veterinarian-grade pet medications, over-the-counter flea and tick control products, and other pet supplies. With a strong focus on making pet care more accessible and affordable, PetIQ Inc has established a significant presence in the US market, catering to the needs of pet owners and their furry companions throughout the country.
PetIQ Inc represents a strong commitment to providing affordable, accessible, and high-quality pet healthcare products and services. With a focus on pet wellness, their corporate philosophy revolves around enhancing the bond between pets and their owners by offering convenient solutions and expert advice. PetIQ Inc strives to make pet healthcare accessible to all through their comprehensive range of over-the-counter products, prescription medications, and veterinary services. By prioritizing affordability without compromising on quality, they aim to improve the overall well-being of pets and contribute positively to their customers' lives. PetIQ Inc's dedication to pet health and their customer-centered approach makes them a trusted and reliable choice for pet owners.
Analysts currently set an average price target of 31.11 USD for the PetIQ stock (median: 31.11 USD), implying +0.4 % versus the latest price. The consensus is based on 11 analyst ratings.
11 analysts currently rate the PetIQ stock: 7 recommend buying, 4 holding and 0 selling. For 2026, analysts expect PetIQ to generate revenue of 1.31 B USD and earnings per share of 1.86 USD.
Converted at the current exchange rate, the PetIQ share trades at 26.81 EUR (30.98 USD).
The PetIQ share (PETQ) is listed on 4 stock exchanges, including: NASDAQ (PETQ), Frankfurt (39L.F), München (39L.MU), Düsseldorf (39L.DU).
PetIQ Inc is a company based in Idaho, USA, specializing in the sale of animal health products and veterinary services. The company operates in three main business areas: retail, prescription medications, and services. In the retail sector, PetIQ Inc offers a wide range of animal health products, including supplements, food and water bowls, pet care products, toys, and treats. These products are sold in various retail outlets, including discount stores, pet supply stores, and online platforms. The company also owns two retail brands, VIP Petcare and VetIQ, which also operate in the USA. The prescription medications sector is another important business area for PetIQ. The company distributes prescription medications for pets, such as antibiotics, painkillers, and anti-parasite medications. These medications are sold through veterinary practices and the company's online shop. PetIQ also has its own brand of prescription medications called PetArmor. Services such as veterinary consultations, vaccinations, and diagnostics are another important branch of PetIQ Inc's business. The company operates mobile veterinary services, which are available in many US states, including VIP Petcare clinics, which are now operating in select Walmart locations. The company follows a growth model through strategic acquisitions to expand its product offering and market presence. An example of this is the acquisition of PetArmor in 2018. Another important aspect of PetIQ's business model is establishing a strong presence in the e-commerce sector through online sales of animal health products and prescription medications. These online sales platforms have experienced rapid growth in recent years, as they provide customers with a convenient way to purchase pet products. PetIQ also has a presence on social media platforms such as Facebook and Twitter to promote its products and services and engage with customers. The company also utilizes various marketing strategies such as promotions, discounts, and seasonal sales to encourage customer loyalty and stimulate customer purchasing behavior. Overall, PetIQ Inc has developed an innovative and diverse business model that allows it to offer a wide range of animal health products and services. The company has established itself as a significant player, providing innovative and affordable solutions for pet owners worldwide to keep their pets healthy. And, importantly, the pet business has gained even more momentum during a global pandemic.
The expected revenue of PetIQ is 1.31 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of PetIQ is 54.42 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of PetIQ is currently 16.62. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the PetIQ stock.
The price-to-sales ratio (P/S) of PetIQ is currently 0.69. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the PetIQ stock.
The Eulerpool Quality Score for PetIQ is 3/10.
The ISIN of PetIQ is US71639T1060. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of PetIQ is A2DU79. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of PetIQ is PETQ. The ticker symbol is used to trade PetIQ shares on the stock exchange.
PetIQ paid dividends every year for the past 0 years.
PetIQ is assigned to the 'Health' sector.
The dividends of PetIQ are distributed in USD.
PetIQ stock
PetIQ Peer Group
PetIQ Ticker
PetIQ FIGI
All fundamentals and in-depth analysis of PetIQ
Our stock analysis for PetIQ stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PetIQ. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.